Chief Scientific Officer · CalciMedica, Inc. · CalciMedica, Inc. — Employee Stock Option (Right to Buy)
Side
A
Value
—
Shares
65.1K
Price
—
Executed
Apr 5, 2025
Disclosed
Apr 7, 2026
Disclosure timeline367 days from execution to publication · legal deadline 2 business days
Apr 5 executedApr 7, 2026 disclosed
CALC · daily
Yahoo Finance chart API
◉This trade, on the day it was made▼Disclosure●Material company filing◯Other disclosed buy◯Other disclosed sellUnofficial public endpoint; daily OHLCV, split-adjusted. Replace with a licensed feed for production.
Grant or award — administrative, little informational value
Relative size+1 / 25
No reported dollar value · new position
Filing timing+15 / 15
Disclosed 262 business days after execution (deadline: 2)
Historical behavior+8 / 15
First recorded trade by this actor in this security
Frequency & clustering0 / 15
No clustered activity in the dataset
Market events0 / 10
No material company filing within 60 days after the trade
The Insider Score measures how far a disclosure deviates from normal filing patterns. A high score is a prompt for research, not evidence of illegal insider trading.
CalciMedica, Inc. — Employee Stock Option (Right to Buy)
Ticker
CALC
Shares
65.1K
Price per share
$0
Execution date (reported)
Apr 5, 2025
Owned after transaction
65.1K shares
Days from execution to publication
367
What this establishes
Stauderman Kenneth A. filed this Form 4 reporting a grant or award of CALC on Apr 5, 2025. It became public on Apr 7, 2026. The filing establishes the reported transaction and the filer's stated role. It does not establish why the trade was made or what the filer knew.
Extraction
Method
Form 4 XML
Confidence
1.00
Chief Scientific Officer
Stauderman Kenneth A.cik:0001969388
Issuer
CalciMedica, Inc.cik:0001534133
Revision history · 0
No field has changed since this record was first ingested.
